Abstract Library

#4540 Retrospective analysis of somatostatin receptors expression in cohort of thoracic neuroendocrine neoplasms with immunohistochemistry method or PET/CT Ga68 DOTA-TATE

Introduction: Somatostatin receptors (SSTRs) expression in cohort of thoracic neuroendocrine neoplasms (NENs) is still not fully described. We attempted to evaluate the SSTR expression by IHC and PET/CT with Ga68 DOTA-TATE, as well as the sensitivity of both methods.

Conference:

Presenting Author: Evdokimova E

Authors: Evdokimova E, Vorobeva M, Zhulikov Y, Markovich A, Gorbunova V,

Keywords: NEN, thoracic, SSTR, IHC, DOTATATE, lung, thymus, mediastinum, LCNC, NET,

#4469 Therapeutic strategy for pancreatic neuroendocrine tumours: An overview of the TNE West Network (2016-2024)

Introduction: Neuroendocrine tumours (NETs) are relatively rare and often diagnosed at an advanced stage, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Conference:

Presenting Author: Bengueddach A

Authors: Bengueddache A, Kehili H, Tidjane A, Tabeti B, Manouni C,

Keywords: neuroendocrine tumour, metastasis, somatostatin analogue, pancreas,

#4196 Metastatic potential and associated mortality in a Greek cοhort of 123 MEN1 patients

Introduction: Prevalence of distant stage disease and overall mortality rates vary considerably among patients with multiple endocrine neoplasia type 1 (MEN1).

Conference:

Presenting Author: Papadopoulou-Marketou N

Authors: Papadopoulou-Marketou N, Daskalakis K, Chondrogianni M, Tsoli M, Kaltsas G,

Keywords: MEN1, pancreatic neuroendocrine tumor, thymus cancer,

#4061 Dissecting the single-cell transcriptome network underlying thymic neuroendocrine tumor and thymus non-malignant tissues

Introduction: Thymic neuroendocrine tumor (TNET) is the rarest subtype among thymic epithelial tumors and NET. Limited understanding of tumor microenvironment (TME) of TNET contributes to the lack of treatment options for this rare tumor type.

Conference:

Presenting Author: Liu M

Authors: Liu M, Lin X, Chen L, Su C, Wen W,

Keywords: thymic neuroendocrine tumor, single-cell RNA sequencing, tumor microenvironment, tumor-associated fibroblasts,

#3945 8-year follow-up reveals therapeutic approaches for patients with neuroendocrine neoplasms – Findings from the TNE West Network: 2016-2023

Introduction: Neuroendocrine tumors (NETs) are relatively rare and often diagnosed late, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Conference:

Presenting Author:

Authors: Bengueddach A, Kehili H, Tidjane A, Benaoum A, Khalifa S,

Keywords: neuroendocrine tumor, metastasis, somatostatin analogues,